Global Preventive Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Preventive Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Preventive Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Preventive Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Preventive Vaccines Segment by Type

2.2.1 Intramuscular Injection

2.2.2 Nasal Spray

2.2.3 Intradermal Shot

2.3 Preventive Vaccines Sales by Type

2.3.1 Global Preventive Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Preventive Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Preventive Vaccines Sale Price by Type (2017-2022)

2.4 Preventive Vaccines Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Other

2.5 Preventive Vaccines Sales by Application

2.5.1 Global Preventive Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Preventive Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Preventive Vaccines Sale Price by Application (2017-2022)

3 Global Preventive Vaccines by Company

3.1 Global Preventive Vaccines Breakdown Data by Company

3.1.1 Global Preventive Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Preventive Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Preventive Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Preventive Vaccines Revenue by Company (2020-2022)

3.2.2 Global Preventive Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Preventive Vaccines Sale Price by Company

3.4 Key Manufacturers Preventive Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Preventive Vaccines Product Location Distribution

3.4.2 Players Preventive Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Preventive Vaccines by Geographic Region

4.1 World Historic Preventive Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Preventive Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Preventive Vaccines Annual Revenue by Geographic Region

4.2 World Historic Preventive Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Preventive Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Preventive Vaccines Annual Revenue by Country/Region

4.3 Americas Preventive Vaccines Sales Growth

4.4 APAC Preventive Vaccines Sales Growth

4.5 Europe Preventive Vaccines Sales Growth

4.6 Middle East & Africa Preventive Vaccines Sales Growth

5 Americas

5.1 Americas Preventive Vaccines Sales by Country

5.1.1 Americas Preventive Vaccines Sales by Country (2017-2022)

5.1.2 Americas Preventive Vaccines Revenue by Country (2017-2022)

5.2 Americas Preventive Vaccines Sales by Type

5.3 Americas Preventive Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Preventive Vaccines Sales by Region

6.1.1 APAC Preventive Vaccines Sales by Region (2017-2022)

6.1.2 APAC Preventive Vaccines Revenue by Region (2017-2022)

6.2 APAC Preventive Vaccines Sales by Type

6.3 APAC Preventive Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Preventive Vaccines by Country

7.1.1 Europe Preventive Vaccines Sales by Country (2017-2022)

7.1.2 Europe Preventive Vaccines Revenue by Country (2017-2022)

7.2 Europe Preventive Vaccines Sales by Type

7.3 Europe Preventive Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Preventive Vaccines by Country

8.1.1 Middle East & Africa Preventive Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Preventive Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Preventive Vaccines Sales by Type

8.3 Middle East & Africa Preventive Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Preventive Vaccines

10.3 Manufacturing Process Analysis of Preventive Vaccines

10.4 Industry Chain Structure of Preventive Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Preventive Vaccines Distributors

11.3 Preventive Vaccines Customer

12 World Forecast Review for Preventive Vaccines by Geographic Region

12.1 Global Preventive Vaccines Market Size Forecast by Region

12.1.1 Global Preventive Vaccines Forecast by Region (2023-2028)

12.1.2 Global Preventive Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Preventive Vaccines Forecast by Type

12.7 Global Preventive Vaccines Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Preventive Vaccines Product Offered

13.1.3 Sanofi Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 AstraZeneca

13.2.1 AstraZeneca Company Information

13.2.2 AstraZeneca Preventive Vaccines Product Offered

13.2.3 AstraZeneca Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Main Business Overview

13.2.5 AstraZeneca Latest Developments

13.3 CSL Ltd

13.3.1 CSL Ltd Company Information

13.3.2 CSL Ltd Preventive Vaccines Product Offered

13.3.3 CSL Ltd Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 CSL Ltd Main Business Overview

13.3.5 CSL Ltd Latest Developments

13.4 Abbott

13.4.1 Abbott Company Information

13.4.2 Abbott Preventive Vaccines Product Offered

13.4.3 Abbott Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Abbott Main Business Overview

13.4.5 Abbott Latest Developments

13.5 GlaxoSmithKline

13.5.1 GlaxoSmithKline Company Information

13.5.2 GlaxoSmithKline Preventive Vaccines Product Offered

13.5.3 GlaxoSmithKline Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline Main Business Overview

13.5.5 GlaxoSmithKline Latest Developments

13.6 Serum Institute of India

13.6.1 Serum Institute of India Company Information

13.6.2 Serum Institute of India Preventive Vaccines Product Offered

13.6.3 Serum Institute of India Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Serum Institute of India Main Business Overview

13.6.5 Serum Institute of India Latest Developments

14 Research Findings and Conclusion

Table 1. Preventive Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Preventive Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Intramuscular Injection

Table 4. Major Players of Nasal Spray

Table 5. Major Players of Intradermal Shot

Table 6. Global Preventive Vaccines Sales by Type (2017-2022) & (K Doses)

Table 7. Global Preventive Vaccines Sales Market Share by Type (2017-2022)

Table 8. Global Preventive Vaccines Revenue by Type (2017-2022) & ($ million)

Table 9. Global Preventive Vaccines Revenue Market Share by Type (2017-2022)

Table 10. Global Preventive Vaccines Sale Price by Type (2017-2022) & (USD/Doses)

Table 11. Global Preventive Vaccines Sales by Application (2017-2022) & (K Doses)

Table 12. Global Preventive Vaccines Sales Market Share by Application (2017-2022)

Table 13. Global Preventive Vaccines Revenue by Application (2017-2022)

Table 14. Global Preventive Vaccines Revenue Market Share by Application (2017-2022)

Table 15. Global Preventive Vaccines Sale Price by Application (2017-2022) & (USD/Doses)

Table 16. Global Preventive Vaccines Sales by Company (2020-2022) & (K Doses)

Table 17. Global Preventive Vaccines Sales Market Share by Company (2020-2022)

Table 18. Global Preventive Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Preventive Vaccines Revenue Market Share by Company (2020-2022)

Table 20. Global Preventive Vaccines Sale Price by Company (2020-2022) & (USD/Doses)

Table 21. Key Manufacturers Preventive Vaccines Producing Area Distribution and Sales Area

Table 22. Players Preventive Vaccines Products Offered

Table 23. Preventive Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Preventive Vaccines Sales by Geographic Region (2017-2022) & (K Doses)

Table 27. Global Preventive Vaccines Sales Market Share Geographic Region (2017-2022)

Table 28. Global Preventive Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Preventive Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Preventive Vaccines Sales by Country/Region (2017-2022) & (K Doses)

Table 31. Global Preventive Vaccines Sales Market Share by Country/Region (2017-2022)

Table 32. Global Preventive Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Preventive Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Preventive Vaccines Sales by Country (2017-2022) & (K Doses)

Table 35. Americas Preventive Vaccines Sales Market Share by Country (2017-2022)

Table 36. Americas Preventive Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Preventive Vaccines Revenue Market Share by Country (2017-2022)

Table 38. Americas Preventive Vaccines Sales by Type (2017-2022) & (K Doses)

Table 39. Americas Preventive Vaccines Sales Market Share by Type (2017-2022)

Table 40. Americas Preventive Vaccines Sales by Application (2017-2022) & (K Doses)

Table 41. Americas Preventive Vaccines Sales Market Share by Application (2017-2022)

Table 42. APAC Preventive Vaccines Sales by Region (2017-2022) & (K Doses)

Table 43. APAC Preventive Vaccines Sales Market Share by Region (2017-2022)

Table 44. APAC Preventive Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Preventive Vaccines Revenue Market Share by Region (2017-2022)

Table 46. APAC Preventive Vaccines Sales by Type (2017-2022) & (K Doses)

Table 47. APAC Preventive Vaccines Sales Market Share by Type (2017-2022)

Table 48. APAC Preventive Vaccines Sales by Application (2017-2022) & (K Doses)

Table 49. APAC Preventive Vaccines Sales Market Share by Application (2017-2022)

Table 50. Europe Preventive Vaccines Sales by Country (2017-2022) & (K Doses)

Table 51. Europe Preventive Vaccines Sales Market Share by Country (2017-2022)

Table 52. Europe Preventive Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Preventive Vaccines Revenue Market Share by Country (2017-2022)

Table 54. Europe Preventive Vaccines Sales by Type (2017-2022) & (K Doses)

Table 55. Europe Preventive Vaccines Sales Market Share by Type (2017-2022)

Table 56. Europe Preventive Vaccines Sales by Application (2017-2022) & (K Doses)

Table 57. Europe Preventive Vaccines Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Preventive Vaccines Sales by Country (2017-2022) & (K Doses)

Table 59. Middle East & Africa Preventive Vaccines Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Preventive Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Preventive Vaccines Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Preventive Vaccines Sales by Type (2017-2022) & (K Doses)

Table 63. Middle East & Africa Preventive Vaccines Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Preventive Vaccines Sales by Application (2017-2022) & (K Doses)

Table 65. Middle East & Africa Preventive Vaccines Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Preventive Vaccines

Table 67. Key Market Challenges & Risks of Preventive Vaccines

Table 68. Key Industry Trends of Preventive Vaccines

Table 69. Preventive Vaccines Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Preventive Vaccines Distributors List

Table 72. Preventive Vaccines Customer List

Table 73. Global Preventive Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 74. Global Preventive Vaccines Sales Market Forecast by Region

Table 75. Global Preventive Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Preventive Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Preventive Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 78. Americas Preventive Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Preventive Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 80. APAC Preventive Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Preventive Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 82. Europe Preventive Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Preventive Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 84. Middle East & Africa Preventive Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Preventive Vaccines Sales Forecast by Type (2023-2028) & (K Doses)

Table 86. Global Preventive Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Preventive Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Preventive Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Preventive Vaccines Sales Forecast by Application (2023-2028) & (K Doses)

Table 90. Global Preventive Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Preventive Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Preventive Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 93. Sanofi Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 94. Sanofi Preventive Vaccines Product Offered

Table 95. Sanofi Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 96. Sanofi Main Business

Table 97. Sanofi Latest Developments

Table 98. AstraZeneca Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 99. AstraZeneca Preventive Vaccines Product Offered

Table 100. AstraZeneca Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 101. AstraZeneca Main Business

Table 102. AstraZeneca Latest Developments

Table 103. CSL Ltd Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 104. CSL Ltd Preventive Vaccines Product Offered

Table 105. CSL Ltd Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 106. CSL Ltd Main Business

Table 107. CSL Ltd Latest Developments

Table 108. Abbott Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 109. Abbott Preventive Vaccines Product Offered

Table 110. Abbott Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 111. Abbott Main Business

Table 112. Abbott Latest Developments

Table 113. GlaxoSmithKline Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 114. GlaxoSmithKline Preventive Vaccines Product Offered

Table 115. GlaxoSmithKline Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 116. GlaxoSmithKline Main Business

Table 117. GlaxoSmithKline Latest Developments

Table 118. Serum Institute of India Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 119. Serum Institute of India Preventive Vaccines Product Offered

Table 120. Serum Institute of India Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 121. Serum Institute of India Main Business

Table 122. Serum Institute of India Latest Developments

List of Figures

Figure 1. Picture of Preventive Vaccines

Figure 2. Preventive Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Preventive Vaccines Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Preventive Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Preventive Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Intramuscular Injection

Figure 10. Product Picture of Nasal Spray

Figure 11. Product Picture of Intradermal Shot

Figure 12. Global Preventive Vaccines Sales Market Share by Type in 2021

Figure 13. Global Preventive Vaccines Revenue Market Share by Type (2017-2022)

Figure 14. Preventive Vaccines Consumed in Hospital

Figure 15. Global Preventive Vaccines Market: Hospital (2017-2022) & (K Doses)

Figure 16. Preventive Vaccines Consumed in Clinic

Figure 17. Global Preventive Vaccines Market: Clinic (2017-2022) & (K Doses)

Figure 18. Preventive Vaccines Consumed in Other

Figure 19. Global Preventive Vaccines Market: Other (2017-2022) & (K Doses)

Figure 20. Global Preventive Vaccines Sales Market Share by Application (2017-2022)

Figure 21. Global Preventive Vaccines Revenue Market Share by Application in 2021

Figure 22. Preventive Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Preventive Vaccines Revenue Market Share by Company in 2021

Figure 24. Global Preventive Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Preventive Vaccines Revenue Market Share by Geographic Region in 2021

Figure 26. Global Preventive Vaccines Sales Market Share by Region (2017-2022)

Figure 27. Global Preventive Vaccines Revenue Market Share by Country/Region in 2021

Figure 28. Americas Preventive Vaccines Sales 2017-2022 (K Doses)

Figure 29. Americas Preventive Vaccines Revenue 2017-2022 ($ Millions)

Figure 30. APAC Preventive Vaccines Sales 2017-2022 (K Doses)

Figure 31. APAC Preventive Vaccines Revenue 2017-2022 ($ Millions)

Figure 32. Europe Preventive Vaccines Sales 2017-2022 (K Doses)

Figure 33. Europe Preventive Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Preventive Vaccines Sales 2017-2022 (K Doses)

Figure 35. Middle East & Africa Preventive Vaccines Revenue 2017-2022 ($ Millions)

Figure 36. Americas Preventive Vaccines Sales Market Share by Country in 2021

Figure 37. Americas Preventive Vaccines Revenue Market Share by Country in 2021

Figure 38. United States Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Preventive Vaccines Sales Market Share by Region in 2021

Figure 43. APAC Preventive Vaccines Revenue Market Share by Regions in 2021

Figure 44. China Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Preventive Vaccines Sales Market Share by Country in 2021

Figure 51. Europe Preventive Vaccines Revenue Market Share by Country in 2021

Figure 52. Germany Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Preventive Vaccines Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Preventive Vaccines Revenue Market Share by Country in 2021

Figure 59. Egypt Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Preventive Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Preventive Vaccines in 2021

Figure 65. Manufacturing Process Analysis of Preventive Vaccines

Figure 66. Industry Chain Structure of Preventive Vaccines

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles